Topics

C-Path, CDISC release therapeutic area standard to drive research forward for CDAD

20:00 EDT 1 May 2019 | AAAS

(Critical Path Institute (C-Path)) The Critical Path Institute (C-Path) and CDISC are pleased to announce the release of a global Therapeutic Area Standard, which describes how to use CDISC standards to represent data in research studies pertaining to Clostridium difficile associated diarrhea (CDAD).

Original Article: C-Path, CDISC release therapeutic area standard to drive research forward for CDAD

NEXT ARTICLE

More From BioPortfolio on "C-Path, CDISC release therapeutic area standard to drive research forward for CDAD"

Quick Search

Relevant Topic

Clostridium difficile (CDI)
A clostridium difficile infection (CDI) is a type of bacterial infection that can affect the digestive system. It most commonly affects people who are staying in hospital.  The symptoms of CDI can range from mild to severe and include: diarrhoe...